What is the purpose and procedure of a HIDA (Hepatobiliary Iminodiacetic Acid) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HIDA Scan: Purpose and Procedure

What is a HIDA Scan?

A HIDA (Hepatobiliary Iminodiacetic Acid) scan is a nuclear medicine imaging study that uses radioactive tracers extracted by hepatocytes and cleared through the biliary system, similar to bilirubin, to evaluate gallbladder and biliary tract function based on physiology rather than anatomy 1.

Primary Clinical Indications

Acute Cholecystitis

HIDA scan has the highest sensitivity and specificity for diagnosing acute cholecystitis compared to other imaging modalities, with sensitivity of 84.2-89.3% versus 67.3% for ultrasound and 59.8% for CT 2. The diagnosis is made by demonstrating non-filling of the gallbladder due to cystic duct obstruction 3, 1.

  • In patients with suspected acute cholecystitis where ultrasound is equivocal but clinical suspicion remains high, HIDA scan should be considered as the next diagnostic step 2, 4
  • The scan visualizes the gallbladder in all normal patients but in none with acute cholecystitis 3
  • When the gallbladder is visualized on HIDA scan, acute cholecystitis is effectively excluded 3

Biliary Dyskinesia and Chronic Acalculous Cholecystitis

CCK-augmented HIDA scanning with calculation of gallbladder ejection fraction is the gold standard functional test for diagnosing biliary dyskinesia 5, 2.

  • An ejection fraction <40% after cholecystokinin (sincalide) infusion indicates abnormal gallbladder function 6
  • This test is primarily indicated for functional gallbladder disorder and chronic acalculous cholecystitis, NOT for acute calculous cholecystitis where cystic duct obstruction is already present 2
  • Standardized protocols require 0.02 μg/kg sincalide infused over 60 minutes for reliable results 2

Other Diagnostic Applications

HIDA scanning aids in diagnosing:

  • Partial biliary obstruction from stones, strictures, or sphincter of Oddi dysfunction 1, 4
  • High-grade biliary obstruction before ductal dilatation occurs, showing persistent hepatogram without biliary clearance 1
  • Biliary leakage post-cholecystectomy or after hepatic transplantation 1, 7

Diagnostic Algorithm

Step 1: Initial Imaging

Begin with abdominal ultrasound as first-line imaging for suspected biliary disease 2, 4.

Step 2: When Ultrasound is Diagnostic

If ultrasound confirms gallstones with signs of cholecystitis, no further imaging is needed 2.

Step 3: When Ultrasound is Equivocal

Consider HIDA scan without CCK to assess for cystic duct obstruction if ultrasound is equivocal for acute cholecystitis 2.

Step 4: For Biliary-Type Pain Without Gallstones

If ultrasound shows no cholelithiasis but biliary colic persists, employ CCK-HIDA scan early as the definitive functional test 5.

Step 5: Alternative Advanced Imaging

CT with IV contrast or MRI/MRCP may be obtained if initial imaging remains inconclusive 4.

Procedure Details

Patient Preparation

  • Patients must fast for several hours before the scan 2
  • This ensures adequate gallbladder filling for accurate assessment

Scan Protocol

  • Radiotracer (99mTc-labeled HIDA analog) is injected intravenously 3, 1
  • Dynamic imaging is performed during the first hour using a gamma camera 3
  • Images and time-activity curves are generated to assess hepatic uptake, biliary excretion, and gallbladder filling 3
  • For functional assessment, CCK is infused after initial imaging to stimulate gallbladder contraction 6

Important Limitations and Pitfalls

False Positives for Acute Cholecystitis

Non-visualization of the gallbladder can occur in:

  • Hepatocellular disease (42% of cases show non-visualization due to poor uptake) 3
  • Biliary obstruction (no visualization due to poor secretion) 3
  • Prolonged fasting or critical illness

Practical Constraints

HIDA scan utilization in clinical practice is limited by required resources, specialized equipment, and time compared to ultrasound 4.

CCK-HIDA Limitations

Despite abnormal ejection fractions, outcomes after cholecystectomy for acalculous disease can be variable, with some studies showing excellent outcomes regardless of ejection fraction results 8.

Clinical Outcomes

For patients with typical biliary pain, normal ultrasound, and abnormal HIDA scan (<40% ejection fraction):

  • 79% remained symptom-free or improved at median 28.5 months follow-up after cholecystectomy 6
  • All surgical specimens showed chronic cholecystitis, with 51% having sludge or microlithiasis 6

References

Research

Nuclear medicine hepatobiliary imaging.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2010

Guideline

Diagnostic Approach for Gallstone Cholecystitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

HIDA scanning in gall-bladder disease.

The British journal of radiology, 1980

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach for Severe Biliary Dyskinesia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The role of (99m)technetium-labelled hepato imino diacetic acid (HIDA) scan in the management of biliary pain.

HPB : the official journal of the International Hepato Pancreato Biliary Association, 2007

Research

Laparoscopic cholecystectomy for acalculous gallbladder disease.

Proceedings (Baylor University. Medical Center), 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.